These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7011618)
1. Immune complex deposits in thyroid glands of patients with Graves' disease: I. Complement system in serum and thyroid gland of patients with Graves' disease. Fujiwara H; Torisu M; Koitabashi Y; Baba T; Esaki H Clin Immunol Immunopathol; 1981 Apr; 19(1):98-108. PubMed ID: 7011618 [No Abstract] [Full Text] [Related]
2. Immune complex deposits in Graves' disease and Hashimoto's thyroiditis. Kalderon AE; Bogaars HA Am J Med; 1977 Nov; 63(5):729-34. PubMed ID: 337799 [TBL] [Abstract][Full Text] [Related]
3. Demonstration of circulating immune complexes in Graves' disease by the Raji cell technique and their relation to different thyroid autoantibodies. Hopf U; Hütteroth TH; Kotulla P Horm Metab Res; 1979 Nov; 11(11):622-8. PubMed ID: 231561 [No Abstract] [Full Text] [Related]
4. Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease. Bogner U; Schleusener H; Wall JR J Clin Endocrinol Metab; 1984 Oct; 59(4):734-8. PubMed ID: 6548225 [TBL] [Abstract][Full Text] [Related]
5. Immune complex deposits in thyroid glands of patients with Graves' disease. II. Anti-thyroglobulin and anti-microsome activities of gamma-globulin eluted from thyroid homogenates. Fujiwara H; Torisu M; Sugisaki T; Okano H Clin Immunol Immunopathol; 1981 Apr; 19(1):109-17. PubMed ID: 6163581 [No Abstract] [Full Text] [Related]
6. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis. Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460 [TBL] [Abstract][Full Text] [Related]
7. Thyroid antigen-mediated glomerulonephritis in Graves' disease. Sato Y; Sasaki M; Kan R; Osaku A; Koyama S; Shibayama S; Sato M; Narumiya K; Takagi T; Kojima M Clin Nephrol; 1989 Jan; 31(1):49-52. PubMed ID: 2521588 [TBL] [Abstract][Full Text] [Related]
8. [A study using FRTL-5 cell for detecting thyroid stimulating antibody activity in serum in patients with Graves disease]. Li J; Gao H; Jin SX Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):392-4, 454. PubMed ID: 1684315 [TBL] [Abstract][Full Text] [Related]
9. The pathogenetic connection between Graves' disease and chronic lymphocytic thyroiditis. (The role and incidence of thyroid stimulating antibodies). Leövey A; Bakó G; Sztojka I; Bordán L; Szabó T; Kálmán K; Balázs C Acta Med Acad Sci Hung; 1982; 39(1-2):1-6. PubMed ID: 6129766 [TBL] [Abstract][Full Text] [Related]
10. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases. Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577 [TBL] [Abstract][Full Text] [Related]
11. Evidence for thyroid antigen-reactive T lymphocytes infiltrating the thyroid gland in Graves' disease. Tötterman TH; Andersson LC; Häyry P Clin Endocrinol (Oxf); 1979 Jul; 11(1):59-68. PubMed ID: 391444 [TBL] [Abstract][Full Text] [Related]
12. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies. Lucas-Martin A; Foz-Sala M; Todd I; Bottazzo GF; Pujol-Borrell R J Clin Endocrinol Metab; 1988 Feb; 66(2):367-75. PubMed ID: 3276724 [TBL] [Abstract][Full Text] [Related]
13. [An immunohistochemical study on human leucocyte antigen-DR in Hashimoto thyroiditis and Graves disease]. Zhang H; Li D; Ouyang A Zhonghua Nei Ke Za Zhi; 1996 May; 35(5):303-5. PubMed ID: 9387612 [TBL] [Abstract][Full Text] [Related]
14. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease. Hopf U; Fiek T; Grün R; Zuschneid W J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440 [TBL] [Abstract][Full Text] [Related]
15. Immune responses in stroma and basement membranes of the Graves' disease thyroid(IgM; IgE, IgG, and complement). Werner SC; Wegelius O; Hsu KC Trans Assoc Am Physicians; 1971; 84():139-43. PubMed ID: 4950610 [No Abstract] [Full Text] [Related]
16. Thyrotropin binding inhibiting antibody (TBIAb) in Graves' disease. Cho WY; Choi HH; Chun HJ; Ahn IM Korean J Intern Med; 1988 Jan; 3(1):45-51. PubMed ID: 2908684 [TBL] [Abstract][Full Text] [Related]
17. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease. O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945 [TBL] [Abstract][Full Text] [Related]
18. The expression and role in T cell adhesion of LFA-3 and ICAM-2 on human thyroid cells. Tandon N; Makgoba MW; Gahmberg CG; Weetman AP Clin Immunol Immunopathol; 1992 Jul; 64(1):30-5. PubMed ID: 1376653 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases. Selenkow HA; Wyman P; Allweiss P Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115 [TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of Graves' disease: an overview. Volpé R Clin Endocrinol Metab; 1978 Mar; 7(1):3-29. PubMed ID: 348355 [No Abstract] [Full Text] [Related] [Next] [New Search]